AMLX
Amylyx Pharmaceuticals, Inc.CIK 0001658551
Showing the last 10 days.Sign up free for 90 days
Insider trades
View all AMLX insider trades| Type | Insider | Shares | Price | Value | Traded | Filed |
|---|---|---|---|---|---|---|
| Exercise | Frates James M Chief Financial Officer | 40,000 | $275K | Nov 10, 2026 | Nov 12, 2026 | |
| Sell | Frates James M Chief Financial Officer | 40,000 | $1.2M | Nov 10, 2026 | Nov 12, 2026 | |
| Sell | Klee Justin B. Co-Chief Executive Officer, Director | 100,000 | $3.0M | Nov 9, 2026 | Nov 12, 2026 | |
| Sell | Cohen Joshua B Co-Chief Executive Officer, Director | 100,000 | $3.0M | Nov 9, 2026 | Nov 12, 2026 |
Earnings
PaidCompany revenue, EPS, net income, and guidance the moment they file, parsed from SEC 8-K earnings releases. Create a free account to get started, then unlock earnings on a paid plan.
- Revenue and adjusted / GAAP EPS per quarter
- GAAP net income with profit and loss at a glance
- Forward EPS guidance when companies provide it